293 related articles for article (PubMed ID: 17446082)
1. Aging and the dendritic cell system: implications for cancer.
Shurin MR; Shurin GV; Chatta GS
Crit Rev Oncol Hematol; 2007 Nov; 64(2):90-105. PubMed ID: 17446082
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells--why can they help and hurt us.
Schäkel K
Exp Dermatol; 2009 Mar; 18(3):264-73. PubMed ID: 19183400
[TBL] [Abstract][Full Text] [Related]
5. Alterations in dendritic cell function in aged mice: potential implications for immunotherapy design.
Paula C; Motta A; Schmitz C; Nunes CP; Souza AP; Bonorino C
Biogerontology; 2009 Feb; 10(1):13-25. PubMed ID: 18553153
[TBL] [Abstract][Full Text] [Related]
6. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production.
Wong CP; Magnusson KR; Ho E
Exp Gerontol; 2010 Feb; 45(2):163-9. PubMed ID: 19932744
[TBL] [Abstract][Full Text] [Related]
7. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools.
Volovitz I; Melzer S; Amar S; Bocsi J; Bloch M; Efroni S; Ram Z; Tárnok A
Int Rev Immunol; 2016; 35(2):116-35. PubMed ID: 27007190
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
[TBL] [Abstract][Full Text] [Related]
10. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC.
Ishikawa S; Nagai S; Sato T; Akadegawa K; Yoneyama H; Zhang YY; Onai N; Matsushima K
Eur J Immunol; 2002 Jul; 32(7):1881-7. PubMed ID: 12115607
[TBL] [Abstract][Full Text] [Related]
11. [Role of immunity and tolerance in renal diseases].
Ranieri E
G Ital Nefrol; 2005; 22(2):140-51. PubMed ID: 15875277
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells as natural adjuvants and modulators of immune response in cancer immunotherapy.
Alli RS; Khar A
Indian J Biochem Biophys; 2002 Dec; 39(6):363-7. PubMed ID: 22905392
[TBL] [Abstract][Full Text] [Related]
13. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
14. The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance.
Moore JR
J Theor Biol; 2014 Sep; 357():86-102. PubMed ID: 24816181
[TBL] [Abstract][Full Text] [Related]
15. Targeting dendritic cells for priming cellular immune responses.
Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
[TBL] [Abstract][Full Text] [Related]
16. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.
Harizi H; Gualde N
Tissue Antigens; 2005 Jun; 65(6):507-14. PubMed ID: 15896197
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells: master regulators of the immune response.
Mellman I
Cancer Immunol Res; 2013 Sep; 1(3):145-9. PubMed ID: 24777676
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.
Vo MC; Lee HJ; Kim JS; Hoang MD; Choi NR; Rhee JH; Lakshmanan VK; Shin SJ; Lee JJ
Oncotarget; 2015 Oct; 6(32):33781-90. PubMed ID: 26418952
[TBL] [Abstract][Full Text] [Related]
19. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell apoptosis: regulation of tolerance versus immunity.
Kushwah R; Hu J
J Immunol; 2010 Jul; 185(2):795-802. PubMed ID: 20601611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
